Table 1.
Patient characteristics
| Character | NO. | % |
| Age | ||
| Mean | 49.7 | |
| Range | 35-70 | |
| Menopausal status | ||
| Pre | 12 | 60 |
| Post | 8 | 40 |
| Clinical presentation | ||
| Mammographically detected | 2 | 10 |
| Clinically detected | 18 | 90 |
| Palpable mass | 15 | 83.30 |
| Nipple discharge | 1 | 5.50 |
| Paget’s | 2 | 11.10 |
| Multicentricity/mulifocality | 5 | 25 |
| Initial diagnostic tool | ||
| FNA | 2 | 10 |
| CNB | 18 | 90 |
| Type of surgery | ||
| Lumpectomy | 5 | 25 |
| Simple mastectomy | 10 | 50 |
| Skin sparing mastectomy | 5 | 25 |
| Tumor size | ||
| < 3 cm | 3 | 15 |
| > 3 cm < 6 cm | 12 | 60 |
| > 6 cm | 5 | 25 |
| Nuclear grade | ||
| Low | 0 | |
| Intermediate | 9 | 45 |
| High | 11 | 55 |
| Histology | ||
| With central necrosis | 11 | 55 |
| Without central necrosis | 9 | 45 |
| Final histology | ||
| Pure DCIS | 14 | 70 |
| DCIS + MIC | 3 | 15 |
| DCIS + IDC | 3 | 15 |
| Hormonal receptors | ||
| ER+ PR+ | 6 | 30 |
| ER- PR- | 10 | 50 |
| Unknown | 4 | 1 |
| Her2/neu | ||
| Her2/neu+ | 9 | 45 |
| Her2/neu- | 4 | 1 |
| Unknown | 7 | 35 |
| Adjuvant radiotherapy | ||
| Yes | 5 | 25 |
| No | 15 | 75 |
FNA: Fine needle aspiration; CNB: Core needle biopsy; DCIS: Ductal carcinoma in situ; IDC: Invasive ductal carcinoma; MIC: Microinvasion; ER: Estrogen receptor; PR: Progesterone receptor.